Author: Mythri Raghunandan

Verily’s Project Baseline is modernizing clinical trials

Posted on by Mythri Raghunandan

Verily, a subsidiary of Alphabet inc. and the sister company of Google Inc. has initiated Project Baseline, with the aim to leverage the collaboration of clinical research and clinical care providers to develop proactive healthcare tools and services. Verily is partnered with Pfizer, Sanofi, Novartis and Otsuka to explore the opportunities in cardiovascular disease, oncology, Read more about Verily’s Project Baseline is modernizing clinical trials[…]

Cloudbyz’s Positive Step Towards Green Earth

Posted on by Mythri Raghunandan

World environment day was celebrated by Cloudbyz at the SeedBall Creation drive organized by Saytrees on Sunday, 9th June 2019. Our employees aka Nature lovers took time out of their weekend and gathered to support a cause, “SeedBall creation Drive” an easy and sustainable way of increasing the green cover. One lakh seed balls were Read more about Cloudbyz’s Positive Step Towards Green Earth[…]

8 Key Challenges to Clinical Trial Budgeting

Posted on by Mythri Raghunandan

Bringing a new drug to the market is an expensive venture and can take up to 10 to 15 years from discovery to launch. Clinical trial costs are increasing and so is the complexity of managing it. According to the Tufts CSDD March 2019 Report, Sponsors are spending more on CROs for developing new medicines Read more about 8 Key Challenges to Clinical Trial Budgeting[…]